ACADS and colorectal cancer: By subcutaneously injecting colorectal cancer cells (CT26) into Balb/c and Balb/cByJ mice to construct a mouse subcutaneous tumor model, we observed that the deletion of ACADS in mice resulted in the significantly accelerated growth of colorectal cancer (Figure 5A).